When was MRL Ventures Fund founded?

MRL Ventures Fund was founded in 2015.

Where is MRL Ventures Fund headquartered?

MRL Ventures Fund is headquartered in Cambridge, MA.

What is MRL Ventures Fund's total asset value?

MRL Ventures Fund has around in total assets under management.

How many investments has MRL Ventures Fund made?

MRL Ventures Fund has made 52 investments.

What has MRL Ventures Fund invested in?

MRL Ventures Fund has made numerous investments in companies like Aktis Oncology , InduPro , and Insamo within the Drug Discovery and Biotechnology industries.

What has MRL Ventures Fund invested in recently?

MRL Ventures Fund's latest investment was on 30-Sep-2024 in Aktis Oncology , a company within the Drug Discovery industry.

MRL Ventures Fund Investor Profile: Portfolio & Exits

MRL Ventures Fund Overview

Investor Type

Venture Capital

Status

Active

Professionals

5

Investments

52

Portfolio

16

Exits

18

MRL Ventures Fund General Information

Company Description

Founded in 2015, MRL Ventures Fund is a Corporate Venture Capital arm of Merck & Co headquartered in Cambridge, Massachusetts. The firm seeks to invest in seed and early-stage therapeutics companies.

Business Details

Website

www.mrlv.com

Year Founded

2015

Investor Status

Actively Seeking New Investments

Primary Investor Type

Corporate Venture Capital

Corporate Office

320 Bent Street
4th Floor
Cambridge, MA 02141
United States



MRL Ventures Fund Investments (52)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Aktis Oncology	30-Sep-2024	Early Stage VC	Drug Discovery	Pre-Clinical Trials
InduPro	13-Jun-2024		Biotechnology	Pre-Clinical Trials
Insamo	21-Feb-2024		Biotechnology	Startup
EyeBio	14-Nov-2023		Drug Delivery	Clinical Trials - General
VectorY Therapeutics	13-Nov-2023		Drug Discovery	Pre-Clinical Trials
Mozart Therapeutics	07-Jun-2023		Drug Discovery	Pre-Clinical Trials
Ray Therapeutics	15-May-2023		Drug Discovery	Clinical Trials - Phase 1
Anavo Therapeutics	02-May-2023		Drug Discovery	Generating Revenue
Therini Bio	24-Apr-2023	Later Stage VC	Drug Discovery	Pre-Clinical Trials
Carisma Therapeutics	07-Mar-2023	PIPE	Drug Discovery	Generating Revenue/Not Profitable

You’re viewing 10 of 52 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MRL Ventures Fund Exits (18)

Company Name	Exit Date	Exit Type
EyeBio	12-Jul-2024	Merger/Acquisition
Caraway Therapeutics	20-Nov-2023
Entrada Therapeutics	02-Nov-2021
Xilio Therapeutics	22-Oct-2021
Invivyd	06-Aug-2021
Imago BioSciences	09-Jul-2021
Tidal Therapeutics	09-Apr-2021
Lava Therapeutics	25-Mar-2021
Kymera Therapeutics	21-Aug-2020	IPO
Alector	30-Jan-2020	Public Investment 2nd Offering

You’re viewing 10 of 18 exits. Get the full list »

MRL Ventures Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.